4//SEC Filing
Gordon Murdo 4
Accession 0001127602-25-004776
CIK 0000318154other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:02 PM ET
Size
5.3 KB
Accession
0001127602-25-004776
Insider Transaction Report
Form 4
AMGEN INCAMGN
Gordon Murdo
EVP, Global Commercial Ops
Transactions
- Sale
Common Stock
2025-02-11$294.79/sh−8,771$2,585,644→ 44,186 total
Footnotes (2)
- [F1]The price reported is an average price. The prices ranged from $294.6101 to $294.885 per share. Full information regarding the number of shares purchased at each separate price within the range set forth is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F2]These shares include 773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001642156
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 9:02 PM ET
- Size
- 5.3 KB